Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigeru Fujimoto

Showing results (121-130 of 140) with videos related to

Pageof 14
Sort By:
Journal of Atherosclerosis and Thrombosis|March 4, 2026
P2Y<sub>12</sub> Inhibitor Response By Patient Background Factors: An Exploratory Post Hoc Subgroup Analysis of the ACUTE-PRAS StudyShigeru Fujimoto, Yasuyuki Iguchi, Hiroshi Yamagami, et al.
Neurology. Clinical Practice|May 1, 2023
Stroke in Patients With Common Noncancerous Gynecologic Diseases: A Multicenter Study in JapanKazuo Yamashiro, Takeo Sato, Chikako Nito, et al.
Journal of the Neurological Sciences|March 31, 2020
Cilostazol uncovers covert atrial fibrillation in non-cardioembolic strokeJunya Aoki, Yasuyuki Iguchi, Takao Urabe, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|December 5, 2020
Cilostazol Addition to Aspirin could not Reduce the Neurological Deterioration in TOAST Subtypes: ADS Post-Hoc AnalysisJunya Aoki, Yasuyuki Iguchi, Takao Urabe, et al.
Journal of the American Heart Association|July 27, 2019
Acute Aspirin Plus Cilostazol Dual Therapy for Noncardioembolic Stroke Patients Within 48 Hours of Symptom OnsetJunya Aoki, Yasuyuki Iguchi, Takao Urabe, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 13, 2021
Microbleeds and clinical outcome in acute mild stroke patients treated with antiplatelet therapy: ADS post-hoc analysisJunya Aoki, Yasuyuki Iguchi, Takao Urabe, et al.
Stroke|January 26, 2017
YAMATO Study (Tissue-Type Plasminogen Activator and Edaravone Combination Therapy)Junya Aoki, Kazumi Kimura, Naomi Morita, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 30, 2019
The randomized study of endovascular therapy with versus without intravenous tissue plasminogen activator in acute stroke with ICA and M1 occlusion (SKIP study)Kentaro Suzuki, Kazumi Kimura, Masataka Takeuchi, et al.
Journal of Stroke|June 4, 2026
Outcomes of Early Versus Later Anticoagulation in Asian Atrial Fibrillation-Related Stroke: ELAN Subgroup AnalysisTakeshi Yoshimoto, Masafumi Ihara, P N Sylaja, et al.
JMIR Research Protocols|April 13, 2023
Detection of Atrial Fibrillation Using Insertable Cardiac Monitors in Patients With Cryptogenic Stroke in Japan (the LOOK Study): Protocol for a Prospective Multicenter Observational StudySatoshi Suda, Takehiro Katano, Kazuo Kitagawa, et al.
Pageof 14

Showing results (121-130 of 140) with videos related to

Sort By:
Pageof 14
Journal of Atherosclerosis and Thrombosis|March 4, 2026
P2Y<sub>12</sub> Inhibitor Response By Patient Background Factors: An Exploratory Post Hoc Subgroup Analysis of the ACUTE-PRAS StudyShigeru Fujimoto, Yasuyuki Iguchi, Hiroshi Yamagami, et al.
Neurology. Clinical Practice|May 1, 2023
Stroke in Patients With Common Noncancerous Gynecologic Diseases: A Multicenter Study in JapanKazuo Yamashiro, Takeo Sato, Chikako Nito, et al.
Journal of the Neurological Sciences|March 31, 2020
Cilostazol uncovers covert atrial fibrillation in non-cardioembolic strokeJunya Aoki, Yasuyuki Iguchi, Takao Urabe, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|December 5, 2020
Cilostazol Addition to Aspirin could not Reduce the Neurological Deterioration in TOAST Subtypes: ADS Post-Hoc AnalysisJunya Aoki, Yasuyuki Iguchi, Takao Urabe, et al.
Journal of the American Heart Association|July 27, 2019
Acute Aspirin Plus Cilostazol Dual Therapy for Noncardioembolic Stroke Patients Within 48 Hours of Symptom OnsetJunya Aoki, Yasuyuki Iguchi, Takao Urabe, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 13, 2021
Microbleeds and clinical outcome in acute mild stroke patients treated with antiplatelet therapy: ADS post-hoc analysisJunya Aoki, Yasuyuki Iguchi, Takao Urabe, et al.
Stroke|January 26, 2017
YAMATO Study (Tissue-Type Plasminogen Activator and Edaravone Combination Therapy)Junya Aoki, Kazumi Kimura, Naomi Morita, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 30, 2019
The randomized study of endovascular therapy with versus without intravenous tissue plasminogen activator in acute stroke with ICA and M1 occlusion (SKIP study)Kentaro Suzuki, Kazumi Kimura, Masataka Takeuchi, et al.
Journal of Stroke|June 4, 2026
Outcomes of Early Versus Later Anticoagulation in Asian Atrial Fibrillation-Related Stroke: ELAN Subgroup AnalysisTakeshi Yoshimoto, Masafumi Ihara, P N Sylaja, et al.
JMIR Research Protocols|April 13, 2023
Detection of Atrial Fibrillation Using Insertable Cardiac Monitors in Patients With Cryptogenic Stroke in Japan (the LOOK Study): Protocol for a Prospective Multicenter Observational StudySatoshi Suda, Takehiro Katano, Kazuo Kitagawa, et al.
Pageof 14